The researchers discovered that a statin called pitavastatin efficiently decreases IL-33 expression by preventing the activation of the TBK1-IRF3 signalling pathway.
Explore the frontiers of Biotechnology, Pharma industry and Science with BiotechReality.com. We publish news, reports, and articles. We are exclusively publishing fellowship and studentship updates to light up the way for graduates to find a suitable research position in academia or industry.
The researchers discovered that a statin called pitavastatin efficiently decreases IL-33 expression by preventing the activation of the TBK1-IRF3 signalling pathway.
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary.